Abstract
Objective To assess associations between risks of cardiovascular disease, heart failure, and all cause mortality and different diabetes drugs in people with type 2 diabetes, particularly newer agents, including gliptins...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have